Health and Healthcare
Walgreens Gets To Complete $7 Billion Dollar Alliance Boots Investment
Published:
Last Updated:
Walgreen Co. (NYSE: WAG) has announced that it has completed its investment in Alliance Boots, an international pharmacy-led health and beauty group. The deal has received all regulatory approvals despite the size of the deal.
Today’s announcement said, “The Walgreens investment consists of approximately $4.0 billion in cash and 83.4 million shares of Walgreens common stock in exchange for a 45% equity stake in Alliance Boots. Walgreens has the option to proceed to a full combination in approximately three years’ time by acquiring the remaining 55% of Alliance Boots.”
With a $35.80 share price today, the shares included come to a value of just under $3 billion. That in turn puts the value today of about $7 billion.
Today’s news comes shortly after Walgreen and Express Scripts Holding Company (NASDAQ: ESRX) settled their prescription fight. While this is not quite market-moving news for Walgreen, the deal does show that regulatory agencies will continue to allow large deals even by the most dominant of players in the retail drug sales space as long as they are not evident to be highly monopolistic on the surface.
JON C. OGG
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.